Kimia Pharmaceutical

98 21 66437014

careers Contact Us فارسی EN العربیة

Products

Bitroziga®(Abiraterone)

Metastatic castration-resistant prostate cancer: Bitroziga® 1000 mg (two 500 mg tablets or four 250 mg tablets) orally once daily with prednisone 5 mg orally twice daily. Metastatic cast...

Verzalib® (Abemaciclib)

Verzalib® tablets are taken orally with or without food. • Recommended starting dose in combination with fulvestrant, tamoxifen, or an aromatase inhibitor: 150 mg twice daily. • Recomm...

Empaglibet® (EMPAGLIFLOZIN)

Assess volume status and correct volume depletion before initiating. Recommended dose is 10 mg once daily in the morning, taken with or without food. For additional glycemic control, d...

Trixibet® (Empagliflozin,Linagliptin,Metformin)

Assess renal function before initiating and as clinically indicated. Individualize the starting dose of Trixibet® ER based on the patient’s current regimen and renal function. Initiation o...

Lenvata®(Lenvatinib)

Lenvatinib is a kinase inhibitor that is indicated: • For the treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroi...

Sipomid® (Siponimod)

Assessments are required prior to initiating Sipomid®. Titration is required for treatment initiation. The recommended maintenance dosage is 2 mg. The recommended maintenance ...

Faxibet plus® ER (Dapagliflozin/Metformin)

Individualize the starting dose based on the patient’s current treatment. Assess renal function before initiating and periodically thereafter. To improve glycemic control, for pa...

Teriflunomide

The recommended dose of Teriflunomide is 7 mg or 14 mg orally once daily. Teriflunomide can be taken with or without food.

Dapagliflozin is a Sodium-glucose cotransporter 2 (SGLT2) inhibitor. Dapagliflozin reduces reabsorption of filtered glucose and increases urinary glucose excretion. Dapagliflozin also reduces sodium r...

Rizolung® (Crizotinib)

•Metastatic NSCLC: The recommended dosage is 250 mg orally twice daily. • Systemic ALCL: The recommended dosage is 280 mg/m2 orally twice daily based on body surface area. Unresectab...

Encastry® (enzalutamide)

160 mg (four 40 mg capsules) Enzalutamide administered orally once daily. Enzalutamide can be taken with or without food. Swallow capsules whole, do not chew, dissolve, or open the capsules. ...

For Experts & healthcare professionals

How is technology impacting the quality assurance of our products

in our manufacturing sites many different types of technologies are being implemented to improve the processes of pharmaceutical manufacturing and Quality Assurance which ultimately, creates a safer medicine...

See how we work

Our focus, high quality targeted medicines

At Kimia Pharmaceuticals, we are focused on medicine development in key cancer areas where there are patient needs. Our goal is to bring much needed new treatments to people with cancer.

See how we work

Visit our scientific blogs ONCOMED

Erlotinib & duodenal polyp

erlotinib shows decreased duodenal polyp

Enzalutamide in MCRPC

Read breaking update on Enzalutamide

ONCOGENE

Molecular Diagnostics in Colorectal Carcinoma

Watch related videos for expert opinions and download guidelines in OncoGene online m...

BCR-ABL mutations and CML treatment

BCR-ABL1 mutations that should NOT be treated with bosutinib, dasatinib or nilotinib ...

For patients & care givers

Cancer and its treatment can cause physical symptoms and side effects.They can also cause emotional, social, and financial burden.

Managing these effects is called palliative care or supportive care.

Research shows that palliative care can improve the quality of patient’s life and help their feel more satisfied with the treatment that receive.
The quality of life of patient during treatment is one of the most important concerns we have.

So, our patient care unit is ready to help patients and their families based on their needs.